Physician Profile
Manisha Mittal, MD
Unclaimed ProfileAbout Dr. Mittal
Manisha Mittal, MD is a healthcare provider in Fresno, CA specializing in rheumatology. According to Medicare claims data, Manisha cared for 539 Medicare patients across 207,655 services. The services billed most often include injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered), injection, golimumab, 1 mg, for intravenous use, and injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered).
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it — free, and no identity document with a practice or institutional email.
Education & Training
Specialty
Credentials & Licensing
License numbers are what the provider reported to NPPES when the NPI was issued or updated. NPPES does not verify licensure; confirm current standing with the state licensing board.
Medicare information
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
Contact Information
- (559) 900-4013
- Email not available
Practice Locations
2475 E FIR AVE STE 104
Fresno, CA 93720
Conditions Commonly Evaluated or Treated
Within Rheumatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Conditions
Most searched conditions
- Fibromyalgia
- Gout
- Lupus
- Osteoarthritis
- Psoriatic arthritis
- Rheumatoid arthritis
Autoimmune
- Antiphospholipid Syndrome
- Behçet's Disease
- Dermatomyositis
- Dry Eyes and Mouth
- Granulomatosis with Polyangiitis
- IgA Vasculitis
- IgG4-Related Disease
- Inflammatory myopathy
- Lupus Butterfly Rash
- Positive ANA Blood Test
- Relapsing Polychondritis
Bone
- Paget's Disease of Bone
Bone Health
Connective Tissue
- Hypermobility Syndrome
- Mixed Connective Tissue Disease
- Scleroderma skin disease
- Undifferentiated Connective Tissue Disease
Genetic & Connective Tissue
- Joint Hypermobility
Inflammatory
- Adult-Onset Still's Disease
- Polymyalgia rheumatica
- Rib pain
- Sarcoidosis Joint Pain
Joints
- Baker's Cyst
- Chronic Joint Pain
- Enteropathic Arthritis
- Juvenile Idiopathic Arthritis
- Morning Joint Stiffness
- Palindromic Rheumatism
- Pseudogout
- Reactive Arthritis
- Swollen Fingers or Toes
- Swollen Joints
Nerve & Tendon
Skin & Soft Tissue
- Erythema Nodosum
Skin & Vascular
- Hypothermia And Frostbite At Work
- Mottled Purplish Skin
Soft Tissue
- Lateral hip pain and trochanteric bursitis
- Shoulder Pain
- Tendinitis and tendinopathy
- Trigger finger
Spine & Back
- Ankylosing Spondylitis
- Sacroiliac joint pain
Vascular
- Cold Sensitive Fingers and Toes
- Temporal Arteritis
- Vasculitis
Procedures & services
Most searched procedures
- Arthritis management
- Infusion therapy
- Joint injections
Consultation
- Second Opinion for Autoimmune Disease
Consultations
- Osteoporosis Medication Consultation
Diagnostics & Injections
- Baker's Cyst Aspiration
- Bursa injection
- Carpal tunnel steroid injection
- Joint injection or aspiration
- Knee Joint Injection
- Nailfold Capillaroscopy
- Sacroiliac joint injection
- Salivary Gland Biopsy
- Tendon Sheath Injection
Education & Support
Imaging
- Bone Density Scan Referral
- Joint Ultrasound
Injections
- Ankle Joint Injection
- Finger Joint Injections
- Shoulder Cortisone Injection
- Ultrasound-guided hip injection
- Wrist Cortisone Injection
Lab & Diagnostics
- ANCA Blood Test
- Anti-CCP Antibody Test
- HLA-B27 Genetic Test
- Inflammation Blood Tests
- Joint Fluid Analysis
- Lupus Skin Biopsy
- Myositis Antibody Panel
- Rheumatoid Factor Blood Test
Lab Work
- Autoimmune Blood Panel
- Uric Acid Monitoring
Medication Management
- Biologic medication management
- DMARD Medication Management
- Gout Flare Treatment Plan
- Immunosuppressant Drug Monitoring
- Prolia Injection for Osteoporosis
- Reclast Infusion for Osteoporosis
- Steroid Taper Management
Pain Relief
Regenerative Medicine
- PRP Therapy for Joints
Procedures Most Often Billed to Medicare
207,655 services · 539 patients · 12 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96401 |
889 | More than most peers in Rheumatology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
500 | More often than most peers in Rheumatology |
| Administration of chemotherapy into vein, each additional hour | Treatment | 96415 |
100 | As often as other peers in Rheumatology |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0717 |
158,400 | More than most peers in Rheumatology |
| Injection, golimumab, 1 mg, for intravenous use | Drug given | J1602 |
21,800 | More often than most peers in Rheumatology |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0129 |
11,855 | More often than most peers in Rheumatology |
| Injection, inclisiran, 1 mg | Drug given | J1306 |
7,100 | As often as other peers in Rheumatology |
| Injection, tildrakizumab, 1 mg | Drug given | J3245 |
3,800 | Too few peers to compare |
| Injection, methylprednisolone sodium succinate, 5 mg | Drug given | J2919 |
1,537 | More often than most peers in Rheumatology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
1,140 | Less often than most peers in Rheumatology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Related providers
Connections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Also at this address 2
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
Other rheumatologists in Fresno 8
Same specialty, same city.
Trained at Other 8
Other providers in the same specialty who trained at the same institution.
More connections — 16 related providers in 2 groups
Class of 2005 at Other 8
Providers who graduated from the same medical school in the same year.
Also performs Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 8
Providers in CA who bill this service to Medicare most often.
Common questions
What does Dr. Mittal specialize in?
Dr. Mittal is a rheumatologist in Fresno, CA. That is the designation recorded for this NPI in the federal registry, where it is listed as “Rheumatology”.
NPI registry
Where is Dr. Mittal located?
Dr. Mittal is listed at 2475 E Fir Ave Ste 104, Fresno, CA 93720. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
What is Dr. Mittal's phone number?
The number on file is (559) 900-4013. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
What is Dr. Mittal's NPI number?
Dr. Mittal's National Provider Identifier is 1154627776. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Where did Dr. Mittal go to medical school?
Dr. Mittal attended Other, graduating in 2005. This comes from the CMS National Downloadable File.
CMS public data
How long has Dr. Mittal been practicing?
Dr. Mittal has 21 years experience. Calculated from a graduation year of 2005, reported in the CMS National Downloadable File.
CMS public data
What does Dr. Mittal do most often?
According to Medicare billing data, Dr. Mittal provides treatments such as administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle and administration of chemotherapy into vein, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Has Dr. Mittal confirmed this information?
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Mittal. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.